Invention Application
US20080300260A1 HETEROCYCLIC COMPOUNDS AS POSITIVE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2 (MGLU2 receptor)
有权
作为代谢谷氨酸受体2（MGLU2受体）的阳性调节剂的杂环化合物
- Patent Title: HETEROCYCLIC COMPOUNDS AS POSITIVE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2 (MGLU2 receptor)
- Patent Title (中): 作为代谢谷氨酸受体2（MGLU2受体）的阳性调节剂的杂环化合物
-
Application No.: US12126174Application Date: 2008-05-23
-
Publication No.: US20080300260A1Publication Date: 2008-12-04
- Inventor: Herve GENESTE , Daryl Sauer , Wilfried Braje , Wilhelm Amberg , Mario Mezler , Margaretha Henrica Maria Bakker
- Applicant: Herve GENESTE , Daryl Sauer , Wilfried Braje , Wilhelm Amberg , Mario Mezler , Margaretha Henrica Maria Bakker
- Main IPC: A61K31/496
- IPC: A61K31/496 ; A61K31/44 ; C07D403/02 ; A61P25/18 ; A61P25/06 ; A61P25/00 ; C07D213/72
Abstract:
The present invention relates to heterocyclic compounds which are positive modulators of metabotropic glutamate receptor. The present invention also relates to the use of these compounds for preparing a pharmaceutical composition and to a method of treating a medical disorder, selected from neurological and psychiatric disorders associated with glutamate dysfunction.
Public/Granted literature
- US09242933B2 Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mGlu2 receptor) Public/Granted day:2016-01-26
Information query
IPC分类:
